Pacific Point Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Buy
9,722
+505
+5% +$57.3K 0.53% 66
2025
Q4
$929K Sell
9,217
-505
-5% -$54.8K 0.5% 70
2025
Q3
$1.2M Buy
9,722
+36
+0.4% +$4.47K 0.7% 53
2025
Q2
$1.16M Buy
9,686
+259
+3% +$34.6K 0.63% 46
2025
Q1
$1.39M Buy
9,427
+894
+10% +$137K 0.77% 36
2024
Q4
$1.26M Buy
+8,533
New +$1.4M 0.77% 40

Other funds holding CLX

Pacific Point Advisors's CLX Position: Q1 2026 in Review

Pacific Point Advisors increased its Clorox (CLX) stake by 5.5% in Q1 2026, buying an estimated $57.3K and bringing the position to 9,722 shares worth $1.01M. The position accounts for 0.53% of the portfolio, ranked #66.

Pacific Point Advisors first reported a position in CLX in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.39M in Q1 2025. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Pacific Point Advisors held 9,722 shares of Clorox worth $1.01M as of Q1 2026.
  • Pacific Point Advisors bought 505 Clorox shares in Q1 2026, an estimated $57.3K.
  • Clorox made up 0.53% of Pacific Point Advisors's portfolio in Q1 2026, its #66 holding.
  • Pacific Point Advisors first reported a position in Clorox in Q4 2024 and has held it in 6 quarters since.
  • Pacific Point Advisors's Clorox position peaked at $1.39M in Q1 2025.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Pacific Point Advisors's 13F filing for Q1 2026, filed 4 May 2026.